2023: The year in cardiovascular disease - the year of new and prospective lipid lowering therapies. Can we render dyslipidemia a rare disease by 2024? Arch Med Sci 2023;19(6) Lee más sobre 2023: The year in cardiovascular disease - the year of new and prospective lipid lowering therapies. Can we render dyslipidemia a rare disease by 2024?
A literature review of evidence for primary prevention of overweight and obesity in healthy weight children and adolescents: A report produced by a working group of the Danish Council on Health and Disease Prevention Obesity Reviews 2023 Lee más sobre A literature review of evidence for primary prevention of overweight and obesity in healthy weight children and adolescents: A report produced by a working group of the Danish Council on Health and Disease Prevention
Children and adolescents in the Amsterdam Cohort of Gender Dysphoria: trends in diagnostic- and treatment trajectories during the first 20 years of the Dutch Protocol The Journal of Sexual Medicine January 2023 Lee más sobre Children and adolescents in the Amsterdam Cohort of Gender Dysphoria: trends in diagnostic- and treatment trajectories during the first 20 years of the Dutch Protocol
The Syndrome of Inappropriate Antidiuresis List of authors. Oct 2023 NEJM Lee más sobre The Syndrome of Inappropriate Antidiuresis List of authors.
European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors European Journal of Endocrinology, July 2023 Lee más sobre European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors
2023 ESH Guidelines for the management of arterial hypertension Journal of Hypertension June 2023 Lee más sobre 2023 ESH Guidelines for the management of arterial hypertension
Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial NEJM June 26, 2023 Lee más sobre Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
Extensive expertise in endocrinology: advances in the management of glucocorticoid-induced osteoporosis European Journal of Endocrinology March 2023 Lee más sobre Extensive expertise in endocrinology: advances in the management of glucocorticoid-induced osteoporosis
Approach to the Patient with Prolactinoma The Journal of Clinical Endocrinology & Metabolism, 28 March 2023 Lee más sobre Approach to the Patient with Prolactinoma